FDA OKs Blood-Based Test to Help Detect High-Grade Prostate Tumors

(MedPage Today) — The FDA has approved Cleveland Diagnostics’ blood test to help diagnose high-grade prostate tumors and aid biopsy decisions, the company announced. Called IsoPSA, the in vitro diagnostic kit is indicated for men aged 50…